Evaluation of endpoints for antifungal susceptibility determinations with LY303366

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1387-1391

  Klepser, Michael E ^a   Ernst, Erika J ^a   Ernst, Michael E ^a   Messer, Shawn A ^b   Pfaller, Michael A ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; MORPHOLINE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

EID: 0031833836     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1387     Document Type: Article

References (11)

1. Ernst, M. E., M. E. Klepser, E. J. Wolfe, and M. A. Pfaller. 1996. Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp. Diagn. Microbiol. Infect. Dis. 26:125-131.
2. 1a. Klepser, M. E., E. J. Ernst, M. E. Ernst, S. A. Messer, and M. A. Pfaller. 1997. Evaluation of the endpoint for antifungal susceptibility determinations with LY303366, abstr. F-71, p. 158. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Klepser, M. E., E. J. Ernst, M. E. Ernst, and M. A. Pfaller. 1997. Growth medium effect on the antifungal activity of LY 303366. Diagn. Microbiol. Infect. Dis. 29:227-231.
4. Klepser, M. E., E. J. Ernst, M. E. Ernst, R. E. Lewis, and M. A. Pfaller. 1997. Antifungal time-kill curves, influence of test conditions on results, abstr. D-144, p. 109. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Klepser, M. E., E. J. Wolfe, R. N. Jones, C. H. Nightingale, and M. A. Pfaller. 1997. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Antimicrob. Agents Chemother. 41:1392-1395.
6. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Pearson, R. D., R. T. Steigbigel, H. T. Davis, and S. W. Chapman. 1980. Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18:699-708.
8. Pfaller, M. A., S. A. Messer, and S. Coffman. 1997. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. Antimicrob. Agents Chemother. 41:763-766.
9. Tang, J., T. R. Parr, Jr., W. Turner, M. DeBono, L. Lagrandeur, F. Burkhardt, M. Rodriquez, M. Zweifel, J. Nissen, and K. Clingerman. 1993. LY303366: a noncompetitive inhibitor of (1,3)-β-D-glucan synthases from Candida albicans and Aspergillus fumigatus, abstr. 367, p. 186. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Uzun, Ö., S. Kocagöz, Y. Çetinkaya, S. Arikan, and S. Ünal. 1997. In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates. Antimicrob. Agents Chemother. 41:1156-1157.
11. Zhanel, G. G., J. A. Karlowsky, G. A. J. Harding, T. V. Balko, S. A. Zelenitsky, M. Friesen, A. Kabani, M. Turik, and D. Hoban. 1997. In vitro activity of a new semisynthetic echinocandin. LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob. Agents Chemother. 41:863-865.